Existing drug could treat invasive canine oral tumors
A benign but invasive canine oral cancer is often mistaken for a similar malignant one, leading to misdiagnoses in close to a third of cases. But a new diagnostic tool can now distinguish between the two, according to a new study that also identified a promising FDA-approved drug ready for clinical trials.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →
Children's lung capacity caught up with their peers in less polluted areas once a clean air zone came in, a study shows.
The procedure was carried out last week at a hospital in Sri Lanka, with the stone weighing over three kilograms.
Cancer survivor fights for egg preservation fertility treatment
Scientific breakthrough in Sweden may help with loud snoring swiowanewssource.com
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →